Ron G. Rosenfeld

31.1k total citations · 1 hit paper
448 papers, 23.3k citations indexed

About

Ron G. Rosenfeld is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Ron G. Rosenfeld has authored 448 papers receiving a total of 23.3k indexed citations (citations by other indexed papers that have themselves been cited), including 342 papers in Endocrinology, Diabetes and Metabolism, 156 papers in Molecular Biology and 131 papers in Genetics. Recurrent topics in Ron G. Rosenfeld's work include Growth Hormone and Insulin-like Growth Factors (334 papers), Metabolism, Diabetes, and Cancer (59 papers) and Genetic Syndromes and Imprinting (56 papers). Ron G. Rosenfeld is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (334 papers), Metabolism, Diabetes, and Cancer (59 papers) and Genetic Syndromes and Imprinting (56 papers). Ron G. Rosenfeld collaborates with scholars based in United States, United Kingdom and Germany. Ron G. Rosenfeld's co-authors include Youngman Oh, Raymond L. Hintz, Vivian Hwa, Darrell M. Wilson, Hung Pham, Linda C. Giudice, Pinchas Cohen, Jaime Guevara‐Aguirre, Sharron Gargosky and Arlan L. Rosenbloom and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Ron G. Rosenfeld

442 papers receiving 22.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*

1999 869 citations Vivian Hwa, Youngman Oh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ron G. Rosenfeld United States	83	15.0k	9.4k	6.5k	3.1k	2.7k	448	23.3k
David R. Clemmons United States	87	20.4k 1.4×	12.1k 1.3×	4.6k 0.7×	2.4k 0.8×	3.1k 1.2×	344	30.2k
Robert C. Baxter Australia	78	16.0k 1.1×	10.4k 1.1×	3.3k 0.5×	1.5k 0.5×	2.9k 1.1×	397	22.9k
Charles T. Roberts United States	67	8.4k 0.6×	8.4k 0.9×	2.6k 0.4×	1.4k 0.5×	1.2k 0.4×	264	16.9k
John J. Kopchick United States	70	9.3k 0.6×	6.3k 0.7×	3.0k 0.5×	1.7k 0.6×	1.5k 0.5×	458	18.6k
Cheryl A. Conover United States	63	6.8k 0.5×	5.9k 0.6×	1.7k 0.3×	1.8k 0.6×	1.8k 0.7×	239	13.8k
Derek LeRoith United States	64	9.3k 0.6×	8.0k 0.8×	2.4k 0.4×	839 0.3×	1.2k 0.5×	181	16.1k
Subburaman Mohan United States	72	7.8k 0.5×	8.7k 0.9×	3.6k 0.5×	849 0.3×	1.1k 0.4×	366	18.0k
Andrew R. Hoffman United States	76	6.0k 0.4×	7.5k 0.8×	3.1k 0.5×	1.4k 0.5×	901 0.3×	343	18.3k
Michael B. Ranke Germany	60	7.6k 0.5×	5.4k 0.6×	5.0k 0.8×	3.0k 1.0×	1.7k 0.6×	342	14.6k
Raymond L. Hintz United States	66	9.4k 0.6×	4.8k 0.5×	3.5k 0.5×	2.1k 0.7×	1.2k 0.5×	282	15.0k

Countries citing papers authored by Ron G. Rosenfeld

Since Specialization

Citations

This map shows the geographic impact of Ron G. Rosenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron G. Rosenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron G. Rosenfeld more than expected).

Fields of papers citing papers by Ron G. Rosenfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron G. Rosenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron G. Rosenfeld. The network helps show where Ron G. Rosenfeld may publish in the future.

Co-authorship network of co-authors of Ron G. Rosenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Ron G. Rosenfeld. A scholar is included among the top collaborators of Ron G. Rosenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron G. Rosenfeld. Ron G. Rosenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nayak, Satyaprakash, Michael P. Wajnrajch, Joan Korth‐Bradley, et al.. (2025). IGF-1 Assessment During Weekly Somatrogon Treatment in Pediatric Patients With GH Deficiency. Journal of the Endocrine Society. 9(2). bvaf001–bvaf001. 2 indexed citations

Zadik, Zvi, Nataliya Zelinska, Violeta Iotova, et al.. (2023). An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment. Journal of Pediatric Endocrinology and Metabolism. 36(3). 261–269. 15 indexed citations

Iotova, Violeta, et al.. (2019). Long-Term Safety of a Once-Weekly Somatrogon (hGH-CTP): 4-Year Results of a Phase 2 Extension Study in Children with Growth Hormone Deficiency. 92. 1 indexed citations

Child, Christopher J., Werner Blum, Cheri Deal, et al.. (2016). Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes. European Journal of Endocrinology. 174(5). 669–679. 12 indexed citations

Blum, Werner, Cheri Deal, Alan G. Zimmermann, et al.. (2013). Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency. European Journal of Endocrinology. 170(1). 13–21. 32 indexed citations

Child, Christopher J., Astrid Zimmermann, Cliodhna Quigley, et al.. (2012). Mortality in GH-treated (Tx) patients (pts) enrolled in the global genetics and neuroendocrinology of short stature international study (GeNeSIS). 15th International & 14th European Congress of Endocrinology. 29(17). 1152–1158. 1 indexed citations

Akıncı, Ayşehan, Ron G. Rosenfeld, & Vivian Hwa. (2012). A Novel Exonic GHR Splicing Mutation (c.784G>C) in a Patient with Classical Growth Hormone Insensitivity Syndrome. Hormone Research in Paediatrics. 79(1). 32–38. 7 indexed citations

Rosenfeld, Ron G.. (2007). Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency. 4. 2 indexed citations

Chia, Dennis J., Teresa M. Buck, Vivian Hwa, et al.. (2005). Aberrant Folding of a Mutant Stat5b Causes Growth Hormone Insensitivity and Proteasomal Dysfunction. Journal of Biological Chemistry. 281(10). 6552–6558. 24 indexed citations

10.

Hwa, Vivian, Brian M. Little, Eric M. Kofoed, & Ron G. Rosenfeld. (2004). Transcriptional Regulation of Insulin-like Growth Factor-I by Interferon-γ Requires STAT-5b. Journal of Biological Chemistry. 279(4). 2728–2736. 45 indexed citations

11.

Devi, Gayathri R., Cynthia C.T. Sprenger, Stephen R. Plymate, & Ron G. Rosenfeld. (2002). Insulin‐like growth factor binding protein‐3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo. The Prostate. 51(2). 141–152. 24 indexed citations

12.

Rosenfeld, Ron G. & David B. Allen. (2001). Height enhancement in Turner syndrome: Is it clinically significant?. The Endocrinologist. 11. 2 indexed citations

13.

Burren, Christine, Katie A. Woods, Steven J. Rose, et al.. (2001). Clinical and Endocrine Characteristics in Atypical and Classical Growth Hormone Insensitivity Syndrome. Hormone Research in Paediatrics. 55(3). 125–130. 47 indexed citations

14.

Vorwerk, Peter, et al.. (2000). CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL). British Journal of Cancer. 83(6). 756–760. 25 indexed citations

15.

Rosenfeld, Ron G. & Charles T. Roberts. (1999). The IGF System. Humana Press eBooks. 29 indexed citations

16.

Oh, Youngman & Ron G. Rosenfeld. (1998). Old and new concepts of insulin-like growth factor binding proteins. Journal of Endocrinological Investigation. 21(8). 86–92. 2 indexed citations

17.

Rajah, Roopmathy, Thanh Vu, Andrew R. Hoffman, et al.. (1997). Decreased Expression of Wilms’ Tumor Gene WT-1 and Elevated Expression of Insulin Growth Factor-II (IGF-II) and Type 1 IGF Receptor Genes in Prostatic Stromal Cells from Patients with Benign Prostatic Hyperplasia¹. The Journal of Clinical Endocrinology & Metabolism. 82(7). 2198–2203. 42 indexed citations

18.

Beukers, Margot W., Youngman Oh, Heping Zhang, Nicholas Ling, & Ron G. Rosenfeld. (1991). [Leu²⁷] INSULIN-LIKE GROWTH FACTOR II IS HIGHLY SELECTIVE FOR THE TYPE-II IGF RECEPTOR IN BINDING, CROSS-LINKING AND THYMIDINE INCORPORATION EXPERIMENTS. Endocrinology. 128(2). 1201–1203. 78 indexed citations

19.

Powell, D.R., Ron G. Rosenfeld, & Raymond L. Hintz. (1988). Effects of grwoth hormone therapy and malnutrition on the growth of rats with renal failure. Pediatric Nephrology. 2(4). 425–430. 40 indexed citations

20.

Rosenfeld, Ron G., Raymond L. Hintz, A Johanson, et al.. (1986). Methionyl human growth hormone and oxandrolone in Turner syndrome: Preliminary results of a prospective randomized trial. The Journal of Pediatrics. 109(6). 936–943. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact